Global Oxytocic Pharmaceuticals Market size was valued at US$ 3.52 Bn in 2022 and the total revenue is expected to grow at 4.3% through 2022 to 2029, reaching nearly US$ 4.73 Bn.Global Oxytocic Pharmaceuticals Market Overview:
Oxytocics are a class of medicines used at the end of pregnancy, during labor, and after delivery to cause the smooth musculature of the uterus to contract selectively. Oxytocic medications are used in maternity for a variety of purposes, including induction of labor, labor arrest treatment, contraction stress testing, labor management, and the treatment of uterine atony and postpartum hemorrhage. In the event of a miscarriage, the medication is also used to terminate the fetus. Following a C-section, oxytocic medications are given to prevent uterine atony. Due to the lack of vasopressin, synthetic oxytocin derivatives might cause an antidiuretic effect.To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2018 to forecast the market through 2029. 2022 is considered a base year however 2022's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report.
Global Oxytocic Pharmaceuticals Market Dynamics:
The key reason driving the growth of the oxytocic pharmaceuticals market is an increase in the trend of giving birth in hospitals rather than at home, as well as an increase in the number of caesarian procedures. Furthermore, the numerous types of goods offered by various firms related to oxytocic drugs in order to acquire market share are causing competition in the oxytocic pharmaceuticals industry. The primary issues limiting the growth of the oxytocic pharmaceutical industry are the negative effects associated with oxytocic medications that cause excessive bleeding following vaginal birth due to postpartum hemorrhage. Over the projected period, sales of the market will be driven by improvements in newer oxytocic medicines through license agreements. Furthermore, increasing the use of Antepartum oxytocin injection to increase uterine contractions will have a good impact on oxytocic pharmaceutical demand. Manufacturers are focused on methods such as new Treatment Type innovations, alliances, and expansions to increase their Treatment Type range as competition is projected to rise in the future years. Several oxytocic products are available from well-known companies. The most prominent brands contending for a greater portion of the worldwide oxytocic market include Pitocin, Oxytocin, Evatocin, Syntocinon, Pitocin, Duratocin, Cytotec, and Tiacinon. However, due to its widespread availability, the synthetic oxytocin derivatives category is expected to dominate the market. Similarly, hospitals are likely to become the market's most important end-use sector. In addition, mergers and acquisitions are still popular tactics among market competitors. Tonix Pharmaceuticals, for example, signed a licensing agreement with Katana Pharmaceuticals in 2022 to expand the use of its intranasal potentiated oxytocin medication to treat metabolic illnesses like obesity, diabetes, and insulin resistance.Global Oxytocic Pharmaceuticals Market Segment Analysis:
The Postpartum hemorrhage (PPH) segment is dominating the Treatment Type segment of the Global Oxytocic Pharmaceuticals Market: Postpartum hemorrhage (PPH), a kind of obstetric hemorrhage, was the main cause of maternal mortality. Every year, 14 million cases of PPH are reported by the World Health Organization (WHO) for the treatment of PPH, oxytocin injection is indicated. 1-2mU/min is the recommended dose for oxytocic medicines. Hipofisina, Evatocin, Litocin, Pitogin, Piton-S, and Obcin Octocin are some of the major brands commercially marketed. Carbetocin, Misoprostol, and Syntocinon, among other oxytocic medicines, have yet to get FDA approval.The Hospital segment is considered to supplement the growth of the Global Oxytocic Pharmaceuticals Market. The hospital segment is likely to grab more attention in the end-use segment of the global oxytocic pharmaceuticals market with largest market share of 67% in 2022. Oxytocin is extensively used in perinatal medicine and can cause serious side effects on a high dose. Perinatal medicines are used in pregnant women during labor pain and lactating mothers. The injection of oxytocin, which is used to induce labor or intensify contractions, is normally given intravenously in a hospital under medical supervision. Oxytocic drugs are also used for several indications in obstetrics and obstetric anesthesia in hospitals. Synthetic oxytocin is a widely used drug as compare to natural oxytocin. Moreover, a high dose of synthetic oxytocin may lead to various side effects inpatient. However, oxytocin is widely prescribed in hospitals as compared to any other clinic. Moreover, the larger availability of drugs in hospital pharmacies is a key factor responsible for the growth of the market.
Global Oxytocic Pharmaceuticals Market Regional Insights:
North America is likely to boost the growth of the oxytocin Pharmaceuticals market. North America is estimated to grow at a CAGR of 4.9% in the forecast period. Resulting in an increase in caesarian procedures, involvement in R&D, government initiatives, great advancement in the field of oxytocic functions, awareness regarding maternal care, and developed healthcare infrastructure, North America is expected to dominate the oxytocic pharmaceuticals market, followed by Europe and the Asia Pacific. further, Due to a growth in labour induction techniques in the region, post-partum bleeding has become the most appealing indication segment. Also, market competitors in the region are increasing their innovations in medication combinations and improving the pharmacological action of drug activities. MEA is likely to support the growth of the oxytocic pharmaceuticals market in the forecast period. Leading to a shortage of sufficient nutrition for pregnant women, the MEA region has the highest frequency of post-partum hemorrhage of all the regions. Due to a lack of healthcare infrastructure and understanding about pregnancy-related issues among African women, Africa's contribution to the prevalence of postpartum hemorrhage in the MEA area is on the higher end. In African countries, the prevalence of postpartum hemorrhage is as high as 25.7 %, while in Asian countries it is as low as 8.5 percent. The objective of the report is to present a comprehensive analysis of the Global Oxytocic Pharmaceuticals Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Oxytocic Pharmaceuticals Market dynamics, structure by analyzing the market segments and project the Global Oxytocic Pharmaceuticals Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Oxytocic Pharmaceuticals Market make the report investor’s guide.Global Oxytocic Pharmaceuticals Market Scope: Inquire before buying
Oxytocic Pharmaceuticals Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 3.52 Bn. Forecast Period 2023 to 2029 CAGR: 4.3% Market Size in 2029: US $ 4.73 Bn. Segments Covered: by Treatment Type Pre-eclampsia/Eclampsia Postpartum Hemorrhage Others by End User Hospitals Maternity Centre Clinics Global Oxytocic Pharmaceuticals Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Oxytocic Pharmaceuticals Market Key Player
1. App Pharmaceuticals LLC 2. Teva Parenteral Medicines Inc. 3. Abbott laboratories 4. JHP Pharmaceuticals LLC 5. Novartis Pharmaceuticals Corporation 6. LBS Labs, 7. Baxter Healthcare Corporation 8. Pfizer Inc 9. Fresenius Kabi 10.Biofutura 11.Ferring 12.Biofutura SpA 13.Dr. Reddy’s Laboratories 14.Granules Pharmaceuticals, Inc., FAQs: 1. What is the global Oxytocic Pharmaceuticals market value in 2022? Ans: Global Oxytocic Pharmaceuticals market value in 2022 was estimated as 3.52 Billion USD. 2. What is the global Oxytocic Pharmaceuticals market growth? Ans: The global Oxytocic Pharmaceuticals market is anticipated to grow with a CAGR of 4.3% in the forecast period and is likely to reach USD 4.73 Billion by the end of 2029. 3. Which End-User segment is expected to dominate the global Oxytocic Pharmaceuticals market during the forecast period? Ans: The Hospital segment is projected to lead the market growth and held the largest market share of 67% in 2022, owing to increase in caesarian procedures and increasing birth rate. 4. Who are the key players in the Oxytocic Pharmaceuticals market? Ans: Some key players operating in the Oxytocic Pharmaceuticals market include App Pharmaceuticals LLC, Teva Parenteral Medicines Inc., Abbott laboratories, JHP Pharmaceuticals LLC, and Novartis Pharmaceuticals Corporation. 5. What is the key driving factor for the growth of the global Oxytocic Pharmaceuticals market? Ans: Key factors that are driving the Oxytocic Pharmaceuticals market growth include Highly fragmented market and increasing licensing activities are key trends observed in the market and Increasing labor induction procedures, growing prevalence of PPH, and prequalification from WHO will drive the sales of Oxytocic Pharmaceuticals.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Oxytocic Pharmaceuticals Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Oxytocic Pharmaceuticals Market 3.4. Geographical Snapshot of the Oxytocic Pharmaceuticals Market, By Manufacturer share 4. Global Oxytocic Pharmaceuticals Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Oxytocic Pharmaceuticals Market 5. Supply Side and Demand Side Indicators 6. Global Oxytocic Pharmaceuticals Market Analysis and Forecast, 2022-2029 6.1. Global Oxytocic Pharmaceuticals Market Size & Y-o-Y Growth Analysis. 7. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 7.1.1. Pre-eclampsia/Eclampsia 7.1.2. Postpartum Hemorrhage 7.1.3. Others 7.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 7.2.1. Hospitals 7.2.2. Maternity Centre 7.2.3. Clinics 8. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 9.1.1. Pre-eclampsia/Eclampsia 9.1.2. Postpartum Hemorrhage 9.1.3. Others 9.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 9.2.1. Hospitals 9.2.2. Maternity Centre 9.2.3. Clinics 10. North America Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 12. Canada Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 13. Mexico Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 14. Europe Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 15. Europe Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 17. France Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 18. Germany Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 19. Italy Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 20. Spain Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 21. Sweden Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 22. CIS Countries Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 23. Rest of Europe Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 24. Asia Pacific Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 25. Asia Pacific Oxytocic Pharmaceuticals Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 27. India Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 28. Japan Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 29. South Korea Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 30. Australia Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 31. ASEAN Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 32. Rest of Asia Pacific Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 33. Middle East Africa Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 34. Middle East Africa Oxytocic Pharmaceuticals Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 36. GCC Countries Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 38. Nigeria Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 39. Rest of ME&A Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 40. South America Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 41. South America Oxytocic Pharmaceuticals Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 43. Argentina Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 44. Rest of South America Oxytocic Pharmaceuticals Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Treatment Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Oxytocic Pharmaceuticals Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Novartis AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. App Pharmaceuticals LLC 45.3.3. Teva Parenteral Medicines Inc. 45.3.4. Abbott laboratories 45.3.5. JHP Pharmaceuticals LLC 45.3.6. Novartis Pharmaceuticals Corporation 45.3.7. LBS Labs, 45.3.8. Baxter Healthcare Corporation 45.3.9. Pfizer Inc 45.3.10. Fresenius Kaci 45.3.11. Biofutura 45.3.12. Ferring 45.3.13. Biofutura SpA 45.3.14. Dr. Reddy’s Laboratories 45.3.15. Granules Pharmaceuticals, Inc. 46. Primary Key Insights